The R&D practice helps life science and pharma clients identify and validate biological and disease targets critical to drug and diagnostic development​.

This includes drug discovery, preclinical, clinical, proof-of-concept, and regulatory activities by providing data and knowledge across the drug discovery and development spectrum​. By providing perspective, data and insights garnered through 30+ years of industry leadership., we complement client teams in generating long term value.​

Our R&D team is also home to the Centre for Medicine Research (CMR) a highly reputable source of pharmaceutical industry metrics and insights.

arrow_forwardMeet our R&D experts

Discovery and translational science

We take pride in advancing our client’s research programs and gaining new biological insights by answering complex research questions. We enable your discovery, pre-clinical and translational activities through a combination of trusted data, powerful tools, high quality analysis and effective communication.

Offerings include: ​

  • Multi-OMICs data analysis and integration
  • Machine learning and statistical modeling for target identification, biomarker discovery and patient stratification
  • Systems biology applications for indication prioritization and drug repurposing
  • Adverse Outcome Pathway and custom pathway map reconstruction for understanding disease and treatment mechanisms
  • Data management workflows including curation​​, ontology mapping, analytics and visualization
  • Literature review​ and scientific writing
  • Bioinformatics algorithm implementation and benchmarking


Our highly experienced international experts is dedicated to empowering you to stay ahead of compliance risks, accelerate your pipeline and build robust regulatory strategies using data and a deep understanding of local, national and international regulations. Our global experts can support with your understanding and implementation of the ever-dynamic regulatory environment in the areas of small molecules, Biologics, Med devices, IVDs, Combination products, Cosmetics, Nutraceuticals, Food regulations, GMOs and Agrochemicals.​

​Offerings include:​

  • Regulatory intelligence ​
  • Regulatory strategy
  • GxP compliance​

New services for 2024

Regulatory Strategy Assessment​

Regulatory Strategy Assessment

A roadmap for regulatory approval for new product development and market launch.

“I am developing a new product and I need to understand the regulatory requirements to launch it across international markets.”

arrow_forwardExplore with an expert

Clinical Trial Optimization​

Clinical Trial Optimisation

Determine the right design to optimize efficiency and efficacy for your clinical trial.

53% of all trials need to amend their protocols after initiation due to sub-optimal protocols.

arrow_forwardExplore with an expert

Indication Prioritization

Indication Prioritisation

Expand indication space for your asset considering biological mechanism, competitive landscape and epidemiology of the disease.

We apply advanced AI to Clarivate proprietary datasets spanning the entire Drug Development lifecycle.

arrow_forwardExplore with an expert

Center for Medicines Research (CMR)

The Centre for Medicines Research (CMR) International, is a leader in biopharmaceutical R&D performance analytics. For over 25 years, CMR has worked with the leading global biopharmaceutical companies to assess R&D and Clinical productivity and provide actionable data and insights.

CMR’s performance analytics programmes have been the gold standard for collecting and reporting R&D operations. Data are collected directly from participating biopharmaceutical companies, validated, standardised, and combined into a large, blinded reporting database. The datasets apply unique depth and historical context to uncover reliable industry trends.

Offerings include: ​

arrow_forwardFind out more about CMR

Biopharma R&D solutions

Pinpoint your ideal patient and address true patients’ needs through discovering and designing treatments with comprehensive scientific and clinical intelligence.

arrow_forwardLearn more

Our latest thought leadership

Let's talk

Learn how Clarivate consultants can provide the insight and foresight across your drug and device lifecycle.

Get in touch